AstraZeneca will cap inhaler costs at $35 per month

The cost-reduction strategy follows a similar move from Boehringer Ingelheim, a rival in the medical device sector.

Source: Washington Post: To Your Health - March 18, 2024 Category: Consumer Health News Authors: Aaron Gregg Source Type: news